|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term marketable securities | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Deferred transaction costs | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Prepaid expenses to related party | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Deferred transaction costs | ||||||||||||||||||||
| Long-term marketable securities | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Accrued research and development expenses | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued expenses and other current liabilities (including $40 and $67 due to a related party) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accrued expenses and other current liabilities (including $40 and $67 due to a related party) | ||||||||||||||||||||
| Convertible promissory notes, net of discount of $1,298 (including $0 and $18,670 due to a related party) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible promissory notes, net of discount of $1,298 (including $0 and $18,670 due to a related party) | ||||||||||||||||||||
| Derivative liabilities (including $0 and $995 due to a related party) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total derivative liabilities (including $0 and $995 due to a related party) | ||||||||||||||||||||
| Tranche liability (including $0 and $331 due to a related party) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total tranche liability (including $0 and $331 due to a related party) | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Amount due to related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total amount due to related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Royalty obligation - related party | ||||||||||||||||||||
| Operating lease liabilities, long-term | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable convertible preferred stock, $0.00001 par value, no shares authorized, issued and outstanding as of December 31, 2025; 75,151,340 shares authorized as of December 31, 2024; 43,151,340 shares issued and outstanding as of December 31, 2024; liquidation preference of $0 as of December 31, 2025 | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock, $0.0001 and $0.0001 par value as of June 30, 2026 and December 31, 2025, respectively; 300,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 23,804,981 and 22,902,418 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
